Chairman of the board to guide the work of enterprises stationed abroad
Release time:
2020-08-14
Guiding Work in Overseas Enterprises
News # July 7 and 8 , Chairman Jiang Xiaomeng, Deputy General Manager Xiang Chongping, and Chief Financial Officer Lan Xiaolong and his party successively went to Anhui Xinbeika and Hubei Daye Jianfeng for investigation and guidance, and put forward requirements for recent key work.
In Anhui Xinbeika, Jiang Xiaomeng and other group leaders went deep into the production, technological transformation workshop and environmental protection transformation construction site to learn more about the current production and operation situation and project progress, and convened management backbones at all levels to discuss and exchange the current production, management and project construction. In view of the focus of New Beika's work this year, Jiang Xiaomeng put forward three requirements: first, to clarify ideas, define goals, and complete the annual work plan with quality and quantity; second, to standardize management, strengthen processes, and ensure that all engineering projects are implemented in accordance with regulations and processes; third, pay close attention to safety and environmental protection, ensure safe production, and zero tolerance for safety and environmental protection accidents. At the same time, Jiang Xiaomeng hopes that New North Card will arrange production reasonably, speed up project construction, and strive to achieve excellent performance and maximize returns to shareholders.
In Daye Peak, Jiang Xiaomeng and members of Daye Peak Team had a discussion to learn more about the production and operation of Daye Peak in the first half of the year, and the progress and effect of technological transformation of firing system, desulfurization system and denitration system. Jiang Xiaomeng fully affirmed the operating performance of Daye Peak in the first half of 2018 . Satisfied with the progress and results of technological transformation. After the meeting, Jiang Xiaomeng and others went deep into the production line to learn about the cost reduction and efficiency increase generated by the new high-definition digital monitoring system in the central control room, the desulfurization efficiency, process flow and environmental emission reduction benefits generated after the completion of the desulfurization project. Jiang Xiaomeng pointed out that Daye Jianfeng, as the first enterprise in Hubei Province to implement desulfurization projects, should not only strengthen relevant publicity and establish a corporate image, but also further improve environmental protection awareness and do a good job in environmental protection management in the follow-up production process, so as to ensure the good and healthy development of enterprises. (Zhou Hengbin Zhu Yong)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page